List of Tables
    Table 1. Cellular Tumor Antigen p53 CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Cellular Tumor Antigen p53 Market Trends
    Table 3. Cellular Tumor Antigen p53 Market Drivers
    Table 4. Cellular Tumor Antigen p53 Market Challenges
    Table 5. Cellular Tumor Antigen p53 Market Restraints
    Table 6. Global Cellular Tumor Antigen p53 Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Cellular Tumor Antigen p53 Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Cellular Tumor Antigen p53 Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Cellular Tumor Antigen p53 Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Cellular Tumor Antigen p53 Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Cellular Tumor Antigen p53 Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Cellular Tumor Antigen p53 Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Cellular Tumor Antigen p53 Sales by Manufacturer, (K Pcs), 2017-2022
    Table 14. Global Cellular Tumor Antigen p53 Sales Share by Manufacturer, 2017-2022
    Table 15. Global Cellular Tumor Antigen p53 Price by Manufacturer (2017-2022) & (USD/Pcs)
    Table 16. Global Cellular Tumor Antigen p53 Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Cellular Tumor Antigen p53 by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cellular Tumor Antigen p53 as of 2021)
    Table 18. Top Players of Cellular Tumor Antigen p53 in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Cellular Tumor Antigen p53 Product Type
    Table 20. Date of International Manufacturers Enter into Cellular Tumor Antigen p53 Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Cellular Tumor Antigen p53 Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Cellular Tumor Antigen p53 Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Cellular Tumor Antigen p53 Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Cellular Tumor Antigen p53 Sales by Players, (K Pcs), 2020, 2021 & 2022
    Table 26. United States Cellular Tumor Antigen p53 Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Cellular Tumor Antigen p53 Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Cellular Tumor Antigen p53 Sales in Volume by Region (2017-2022) & (K Pcs)
    Table 29. Global Cellular Tumor Antigen p53 Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
    Table 30. Global Cellular Tumor Antigen p53 Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Cellular Tumor Antigen p53 Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Cellular Tumor Antigen p53 Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 33. North America Cellular Tumor Antigen p53 Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Cellular Tumor Antigen p53 Sales in Volume by Region (2017-2028) & (K Pcs)
    Table 35. Asia Pacific Cellular Tumor Antigen p53 Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Cellular Tumor Antigen p53 Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 37. Europe Cellular Tumor Antigen p53 Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Cellular Tumor Antigen p53 Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 39. Latin Americaa Cellular Tumor Antigen p53 Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Cellular Tumor Antigen p53 Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 41. Middle East and Africa Cellular Tumor Antigen p53 Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Advaxis, Inc. Corporation Information
    Table 43. Advaxis, Inc. Description and Business Overview
    Table 44. Advaxis, Inc. Cellular Tumor Antigen p53 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 45. Advaxis, Inc. Cellular Tumor Antigen p53 Product
    Table 46. Advaxis, Inc. Recent Development
    Table 47. American Gene Technologies International Inc. Corporation Information
    Table 48. American Gene Technologies International Inc. Description and Business Overview
    Table 49. American Gene Technologies International Inc. Cellular Tumor Antigen p53 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 50. American Gene Technologies International Inc. Product
    Table 51. American Gene Technologies International Inc. Recent Development
    Table 52. Aprea AB Corporation Information
    Table 53. Aprea AB Description and Business Overview
    Table 54. Aprea AB Cellular Tumor Antigen p53 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 55. Aprea AB Product
    Table 56. Aprea AB Recent Development
    Table 57. Cellceutix Corporation Corporation Information
    Table 58. Cellceutix Corporation Description and Business Overview
    Table 59. Cellceutix Corporation Cellular Tumor Antigen p53 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 60. Cellceutix Corporation Product
    Table 61. Cellceutix Corporation Recent Development
    Table 62. Critical Outcome Technologies Inc. Corporation Information
    Table 63. Critical Outcome Technologies Inc. Description and Business Overview
    Table 64. Critical Outcome Technologies Inc. Cellular Tumor Antigen p53 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 65. Critical Outcome Technologies Inc. Product
    Table 66. Critical Outcome Technologies Inc. Recent Development
    Table 67. Eleos Inc. Corporation Information
    Table 68. Eleos Inc. Description and Business Overview
    Table 69. Eleos Inc. Cellular Tumor Antigen p53 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 70. Eleos Inc. Product
    Table 71. Eleos Inc. Recent Development
    Table 72. ORCA Therapeutics B.V. Corporation Information
    Table 73. ORCA Therapeutics B.V. Description and Business Overview
    Table 74. ORCA Therapeutics B.V. Cellular Tumor Antigen p53 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 75. ORCA Therapeutics B.V. Product
    Table 76. ORCA Therapeutics B.V. Recent Development
    Table 77. OSE Pharma SA Corporation Information
    Table 78. OSE Pharma SA Description and Business Overview
    Table 79. OSE Pharma SA Cellular Tumor Antigen p53 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 80. OSE Pharma SA Product
    Table 81. OSE Pharma SA Recent Development
    Table 82. PCI Biotech Holding ASA Corporation Information
    Table 83. PCI Biotech Holding ASA Description and Business Overview
    Table 84. PCI Biotech Holding ASA Cellular Tumor Antigen p53 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 85. PCI Biotech Holding ASA Product
    Table 86. PCI Biotech Holding ASA Recent Development
    Table 87. Quark Pharmaceuticals, Inc. Corporation Information
    Table 88. Quark Pharmaceuticals, Inc. Description and Business Overview
    Table 89. Quark Pharmaceuticals, Inc. Cellular Tumor Antigen p53 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 90. Quark Pharmaceuticals, Inc. Product
    Table 91. Quark Pharmaceuticals, Inc. Recent Development
    Table 92. Stemline Therapeutics, Inc. Corporation Information
    Table 93. Stemline Therapeutics, Inc. Description and Business Overview
    Table 94. Stemline Therapeutics, Inc. Cellular Tumor Antigen p53 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 95. Stemline Therapeutics, Inc. Product
    Table 96. Stemline Therapeutics, Inc. Recent Development
    Table 97. Shenzen SiBiono GeneTech Co., Ltd. Corporation Information
    Table 98. Shenzen SiBiono GeneTech Co., Ltd. Description and Business Overview
    Table 99. Shenzen SiBiono GeneTech Co., Ltd. Cellular Tumor Antigen p53 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 100. Shenzen SiBiono GeneTech Co., Ltd. Product
    Table 101. Shenzen SiBiono GeneTech Co., Ltd. Recent Development
    Table 102. SK Biopharmaceuticals Co., Ltd. Corporation Information
    Table 103. SK Biopharmaceuticals Co., Ltd. Description and Business Overview
    Table 104. SK Biopharmaceuticals Co., Ltd. Cellular Tumor Antigen p53 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 105. SK Biopharmaceuticals Co., Ltd. Product
    Table 106. SK Biopharmaceuticals Co., Ltd. Recent Development
    Table 107. Tara Immuno-Oncology Therapeutics LLC Corporation Information
    Table 108. Tara Immuno-Oncology Therapeutics LLC Description and Business Overview
    Table 109. Tara Immuno-Oncology Therapeutics LLC Cellular Tumor Antigen p53 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 110. Tara Immuno-Oncology Therapeutics LLC Product
    Table 111. Tara Immuno-Oncology Therapeutics LLC Recent Development
    Table 112. Z53 Therapeutics, LLC Corporation Information
    Table 113. Z53 Therapeutics, LLC Description and Business Overview
    Table 114. Z53 Therapeutics, LLC Cellular Tumor Antigen p53 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 115. Z53 Therapeutics, LLC Product
    Table 116. Z53 Therapeutics, LLC Recent Development
    Table 117. Key Raw Materials Lists
    Table 118. Raw Materials Key Suppliers Lists
    Table 119. Cellular Tumor Antigen p53 Customers List
    Table 120. Cellular Tumor Antigen p53 Distributors List
    Table 121. Research Programs/Design for This Report
    Table 122. Key Data Information from Secondary Sources
    Table 123. Key Data Information from Primary Sources
List of Figures
    Figure 1. Cellular Tumor Antigen p53 Product Picture
    Figure 2. Global Cellular Tumor Antigen p53 Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Cellular Tumor Antigen p53 Market Size 2017-2028 (US$ Million)
    Figure 4. Global Cellular Tumor Antigen p53 Sales 2017-2028 (K Pcs)
    Figure 5. United States Cellular Tumor Antigen p53 Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Cellular Tumor Antigen p53 Market Size 2017-2028 (US$ Million)
    Figure 7. United States Cellular Tumor Antigen p53 Sales 2017-2028 (K Pcs)
    Figure 8. United States Cellular Tumor Antigen p53 Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Cellular Tumor Antigen p53 Market Share in Global, in Volume (K Pcs) 2017-2028
    Figure 10. Cellular Tumor Antigen p53 Report Years Considered
    Figure 11. Product Picture of COTI-2
    Figure 12. Product Picture of D-12PGJ3
    Figure 13. Product Picture of APR-246
    Figure 14. Product Picture of ATRN-502
    Figure 15. Product Picture of Cenersen Sodium
    Figure 16. Product Picture of MJ-05
    Figure 17. Product Picture of MX-225
    Figure 18. Product Picture of Others
    Figure 19. Global Cellular Tumor Antigen p53 Market Share by Type in 2022 & 2028
    Figure 20. Global Cellular Tumor Antigen p53 Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 21. Global Cellular Tumor Antigen p53 Sales Market Share in Value by Type (2017-2028)
    Figure 22. Global Cellular Tumor Antigen p53 Sales by Type (2017-2028) & (K Pcs)
    Figure 23. Global Cellular Tumor Antigen p53 Sales Market Share in Volume by Type (2017-2028)
    Figure 24. Global Cellular Tumor Antigen p53 Price by Type (2017-2028) & (USD/Pcs)
    Figure 25. United States Cellular Tumor Antigen p53 Market Share by Type in 2022 & 2028
    Figure 26. United States Cellular Tumor Antigen p53 Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 27. United States Cellular Tumor Antigen p53 Sales Market Share in Value by Type (2017-2028)
    Figure 28. United States Cellular Tumor Antigen p53 Sales by Type (2017-2028) & (K Pcs)
    Figure 29. United States Cellular Tumor Antigen p53 Sales Market Share in Volume by Type (2017-2028)
    Figure 30. United States Cellular Tumor Antigen p53 Price by Type (2017-2028) & (USD/Pcs)
    Figure 31. Product Picture of Ovarian Cancer
    Figure 32. Product Picture of Prostate Cancer
    Figure 33. Product Picture of Brain Cancer
    Figure 34. Product Picture of Others
    Figure 35. Global Cellular Tumor Antigen p53 Market Share by Application in 2022 & 2028
    Figure 36. Global Cellular Tumor Antigen p53 Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 37. Global Cellular Tumor Antigen p53 Sales Market Share in Value by Application (2017-2028)
    Figure 38. Global Cellular Tumor Antigen p53 Sales by Application (2017-2028) & (K Pcs)
    Figure 39. Global Cellular Tumor Antigen p53 Sales Market Share in Volume by Application (2017-2028)
    Figure 40. Global Cellular Tumor Antigen p53 Price by Application (2017-2028) & (USD/Pcs)
    Figure 41. United States Cellular Tumor Antigen p53 Market Share by Application in 2022 & 2028
    Figure 42. United States Cellular Tumor Antigen p53 Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 43. United States Cellular Tumor Antigen p53 Sales Market Share in Value by Application (2017-2028)
    Figure 44. United States Cellular Tumor Antigen p53 Sales by Application (2017-2028) & (K Pcs)
    Figure 45. United States Cellular Tumor Antigen p53 Sales Market Share in Volume by Application (2017-2028)
    Figure 46. United States Cellular Tumor Antigen p53 Price by Application (2017-2028) & (USD/Pcs)
    Figure 47. North America Cellular Tumor Antigen p53 Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 48. North America Cellular Tumor Antigen p53 Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 49. U.S. Cellular Tumor Antigen p53 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Canada Cellular Tumor Antigen p53 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Europe Cellular Tumor Antigen p53 Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 52. Europe Cellular Tumor Antigen p53 Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 53. Germany Cellular Tumor Antigen p53 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. France Cellular Tumor Antigen p53 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. U.K. Cellular Tumor Antigen p53 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Italy Cellular Tumor Antigen p53 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Russia Cellular Tumor Antigen p53 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Asia-Pacific Cellular Tumor Antigen p53 Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 59. Asia-Pacific Cellular Tumor Antigen p53 Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 60. China Cellular Tumor Antigen p53 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Japan Cellular Tumor Antigen p53 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. South Korea Cellular Tumor Antigen p53 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. India Cellular Tumor Antigen p53 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Australia Cellular Tumor Antigen p53 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Taiwan Cellular Tumor Antigen p53 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Indonesia Cellular Tumor Antigen p53 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Thailand Cellular Tumor Antigen p53 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Malaysia Cellular Tumor Antigen p53 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Philippines Cellular Tumor Antigen p53 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Latin America Cellular Tumor Antigen p53 Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 71. Latin America Cellular Tumor Antigen p53 Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 72. Mexico Cellular Tumor Antigen p53 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Brazil Cellular Tumor Antigen p53 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. Argentina Cellular Tumor Antigen p53 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 75. Middle East & Africa Cellular Tumor Antigen p53 Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 76. Middle East & Africa Cellular Tumor Antigen p53 Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 77. Turkey Cellular Tumor Antigen p53 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 78. Saudi Arabia Cellular Tumor Antigen p53 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 79. U.A.E Cellular Tumor Antigen p53 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 80. Cellular Tumor Antigen p53 Value Chain
    Figure 81. Cellular Tumor Antigen p53 Production Process
    Figure 82. Channels of Distribution
    Figure 83. Distributors Profiles
    Figure 84. Bottom-up and Top-down Approaches for This Report
    Figure 85. Data Triangulation
    Figure 86. Key Executives Interviewed